Method and device for determining a light transport parameter in a biological matrix

• US 7,315,752 B2
• Filed: 12/07/2002
• Issued: 01/01/2008
• Est. Priority Date: 12/22/2001
• Status: Active Grant

• Current Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Original Assignee: Roche Diagnostics GmbH (Roche Holding AG)
• Inventors: Hein, Heinz-Michael, Hermann, Marcus, Kraemer, Uwe
• Primary Examiner(s): Winakur; Eric F.
• Assistant Examiner(s): Lin; Jack
• Application Number:
  US10/499,109
• Publication Number:
  US 20050002031A1
• Time in Patent Office: 1,851 Days
• Field of Search: 600/309, 600/310, 600/316, 600/322, 600/344, 600/473, 600/476
• US Class Current: 600/316
• CPC Class Codes: A61B 2562/0233 Special features of optical sensors or probes classified in A61B5/00
• CPC Class Codes: A61B 2562/0242 for varying or adjusting the optical path length in the tissue
• CPC Class Codes: A61B 2562/043 in a linear array
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: G01N 21/49 within a body or fluid

Abstract

A method for the selective determination of the scattering index μ_s of a scattering biological matrix, in particular for the purpose of non-invasive determination of the concentration of glucose in the skin, by means of detection measurements, in each of which light in the form of primary light (9) is irradiated into the biological matrix (5) and an intensity measurement value of secondary light (12) exiting at a detection site (33-40) that is located at different measuring distances (ρ) from the respective light irradiation site (10) during the detection measurements is measured. In order to improve the quality and selectivity of the determination of μ_s, the primary light is irradiated obliquely at an angle between 5° and 85° using a contacting light-guiding element. In at least two detection measurements, the measuring distance (ρ) between the respective light irradiation site (10) and the respective detection site (33-40) corresponds to no more than five times the mean free path length of the light propagating in the biological matrix.

Claims

1. A method for determination of a light transport parameter characteristic of light scattering in skin tissue, the method comprising:

irradiating light at a light irradiation site in at least three detection measurements;

irradiating the light as a primary light at the light irradiation site into the skin tissue through a surface by means of a light-guiding element, wherein the light-guiding element contacts the surface of the skin tissue at the light irradiation site;

irradiating the primary light into the skin tissue at the light irradiation site obliquely at a light irradiation angle between 5° and

85°

relative to a normal on the surface;

detecting light exiting the skin tissue through the surface as a secondary light at a detection site that is located in the at least three detection measurements at different measuring distances from the respective light irradiation site;

measuring an intensity value of the secondary light;

evaluating the light transport parameter which is characteristic of the light scattering in the skin tissue, wherein the light transport parameter is derived by means of an evaluation algorithm from the intensity values measured in the detection measurements, and

wherein in at least two of said detection measurements, the measuring distance between the respective light irradiation site and the respective detection site corresponds to no more than approximately 3.5 mm.

2. The method of claim 1, wherein in at least three detection measurements, the measuring distance between the respective light irradiation site and the respective detection site corresponds to no more than approximately 3.5 mm.

3. The method of claim 1, wherein said at least three detection measurements includes at least four detection measurements and wherein in said at least four detection measurements, the measuring distance between the respective light irradiation site and the respective detection site corresponds to no more than approximately 3.5 mm.

4. The method of claim 1, wherein said only intensity measurement values resulting from detection measurements, in which the measuring distance between the respective light irradiation site and the respective detection site corresponds to no more than approximately 7.0 mm, are included in the evaluation step.

5. The method of claim 1, wherein the detection step comprises detecting the secondary light by means of a light-guiding element which contacts the skin tissue at the detection site.

6. The method of claim 1, wherein the detection step comprises detecting the secondary light at the detection site in a detection direction that runs oblique to the surface, at an angle between 5°

and 85°

relative to a normal on the surface.

7. The method of claim 6, wherein the detection direction is oriented towards the light irradiation site.

8. The method of claim 6, wherein the secondary light is detected on the surface of the skin tissue at a plurality of detection fields each of which comprises a plurality of detection sites, the detection direction being the same for the plurality of detection sites of a detection field, but different for the plurality of detection fields.

9. A method for the determination of an analyte in a biological matrix, the method comprising:

irradiating light at a light irradiation site in at least three detection measurements;

irradiating the light as a primary light at the light irradiation site into the biological matrix through a surface by means of a light-guiding element, wherein the light-guiding element contacts the surface of the biological matrix at the light irradiation site;

irradiating the primary light into the biological matrix at the light irradiation site obliquely at a light irradiation angle between 5° and

85°

relative to a normal on the surface;

detecting light exiting the biological matrix through the surface as a secondary light at a detection site that is located in the at least three detection measurements at different measuring distances from the respective light irradiation site;

measuring an intensity value of the secondary light; and

an evaluation step, wherein the concentration of the analyte in the biological matrix is derived by means of an evaluation algorithm from the intensity values measured of the secondary light in the detection measurements, wherein in at least two detection measurements, the measuring distance between the respective light irradiation site and the respective detection site corresponds to no more than approximately 3.5 mm.

10. The method of claim 9, wherein in at least three detection measurements, the measuring distance between the respective light irradiation site and the respective detection site corresponds to no more than approximately 3.5 mm.

11. The method of claim 9, wherein in at least four detection measurements, the measuring distance between the respective light irradiation site and the respective detection site corresponds to no more than approximately 3.5 mm.

12. The method of claim 9, wherein only intensity measurement values resulting from detection measurements, in which the measuring distance between the respective light irradiation site and the respective detection site corresponds to no more than approximately 7.0 mm, are included in the evaluation step.

13. The method of claim 9, wherein the detection step comprises detecting the secondary light by means of a light-guiding element which contacts the skin tissue at the detection site.

14. The method of claim 9, wherein the detection step comprises detecting the secondary light at the detection site in a detection direction that runs oblique to the surface, at an angle between 5°

and 85°

relative to a normal on the surface.

15. The method of claim 14, wherein the detection direction is oriented towards the light irradiation site.

16. The method of claim 14, wherein the secondary light is detected on the surface of the skin tissue at a plurality of detection fields each of which comprises a plurality of detection sites, the detection direction being the same for the plurality of detection sites of a detection field, but different for the plurality of detection fields.

17. The method of claim 9, wherein in at least two of said detection measurements, the measuring distance between the respective light irradiation site and the respective detection site corresponds to no more than approximately 3.5 mm.

18. A method for determination of a light transport parameter which is characteristic of light scattering in skin tissue, in particular for the purpose of determination of the concentration of glucose in the skin tissue, the method comprising:

irradiating light at a light irradiation site in at least three detection measurements;

irradiating the light as a primary light into the skin tissue through a surface;

irradiating the primary light into the skin tissue at the light irradiation site obliquely at a light irradiation angle between 5° and

85°

relative to a normal on the surface;

detecting light exiting the skin tissue through the surface as a secondary light at a detection site that is located in the at least three detection measurements at different measuring distances from the respective light irradiation site;

measuring an intensity value of the secondary light; and

an evaluating step, in which the light transport parameter which is characteristic of the light scattering in the skin tissue is derived by means of an evaluation algorithm from the intensity values measured in the detection measurements,

wherein the evaluation algorithm includes the following steps;

(a) determining by means of a numerical simulation for a typical value of optical scattering (μ

s,MC) the theoretical dependence of the intensity (I) of the secondary light from the measuring distance (ρ

) and the optical absorption (μ

a);

(b) storing the result of the simulation as a lookup table by which an intensity value (I(ρ

,μ

a)) is assigned to predetermined values of the measuring distance (ρ

) and optical absorption (μ

a); and

(c) determining the parameter (μ

s) which is characteristic of the light scattering in the skin tissue by means of a fit procedure, in which for a plurality of different values of the light transport parameters (μ

a, μ

s) characterizing the light transport in the skin tissue the dependence of the intensity (I) on the measuring distance (ρ

) is calculated and the result is compared to the intensity measurement values measured in the detection measurements in order to determine those values of the light transport parameters (μ

a, ρ

s) at which an optimal agreement of the calculated dependence of the intensity (I) on the measuring distance (ρ

) and the respective intensity measurement values is achieved, wherein step c) comprises the following substeps;

c1) calculating a scaling factor (s) from the relation of any selected optical scattering value (μ

s) to the typical optical scattering (μ

s,MC) used in step a);

c2) converting the independent variables (ρ

, μ

a) of the lookup table stored in step b) by means of the scaling factor (s);

c3) calculating the dependence of the intensity (I) on the optical absorption (μ

a) and the measuring distance (ρ

) at the selected optical scattering value (μ

s) by means of the converted variables on the basis of the values stored in the lookup table.

19. The method according to claim 18, wherein the detection measurements are performed by means of a portable analysis instrument which includes a first computer system for performing a part of the evaluation algorithm, wherein steps a) and b) are performed by a second computer system which is separate from the portable analysis instrument.

20. A device for determination of a light transport parameter which is characteristic of light scattering in skin tissue, in particular for the purpose of determination of the concentration of glucose in the skin tissue, the device comprising:

a measuring head having at least one light irradiation means for irradiating the primary light at at least one light irradiation site and at least one detection means for detecting the secondary light at at least one detection site;

wherein the at least one irradiation site and the at least one detection site are arranged such that their measuring distance (ρ

) is not more than approximately 3.5 mm; and

wherein the light irradiation means includes a light-guiding element that contacts the surface of the skin tissue at the selected light irradiation site and are arranged in such a manner that the primary light is irradiated into the skin tissue obliquely at the light irradiation site at a light irradiation angle between 5° and

85°

relative to a normal on the surface.